Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for MHTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2024 -0.017M
March 31, 2024 -0.042M
December 31, 2023 -0.014M
September 30, 2023 -0.037M
June 30, 2023 -0.064M
March 31, 2023 -0.075M
December 31, 2022 -0.087M
September 30, 2022 -0.088M
June 30, 2022 -0.063M
March 31, 2022 -0.111M
December 31, 2021 -0.124M
September 30, 2021 -0.099M
June 30, 2021 -0.102M
March 31, 2021 -0.096M
December 31, 2020 -0.121M
September 30, 2020 -0.085M
June 30, 2020 -0.082M
March 31, 2020 -0.10M
December 31, 2019 -0.073M
September 30, 2019 -0.088M
June 30, 2019 -0.056M
March 31, 2019 -0.099M
December 31, 2018 -0.155M
September 30, 2018 -0.388M
June 30, 2018 0.065M
Date Value
March 31, 2018 -0.204M
December 31, 2017 0.785M
September 30, 2017 -0.139M
June 30, 2017 -0.30M
March 31, 2017 -1.137M
December 31, 2016 -0.937M
September 30, 2016 -0.759M
June 30, 2016 -1.424M
March 31, 2016 -1.439M
December 31, 2015 -1.106M
September 30, 2015 -1.407M
June 30, 2015 -1.177M
March 31, 2015 7.105M
December 31, 2014 -0.808M
September 30, 2014 -0.923M
June 30, 2014 -0.102M
March 31, 2014 -0.702M
December 31, 2013 -0.505M
September 30, 2013 -0.479M
June 30, 2013 -0.598M
March 31, 2013 0.618M
December 31, 2012 -0.374M
September 30, 2012 -0.376M
June 30, 2012 -0.486M
March 31, 2012 0.158M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -14.15M
Exicure, Inc. -0.887M
Century Therapeutics, Inc. -19.83M
Absci Corp. -27.56M
Celularity, Inc. -5.103M